Personalis, Inc. PE Ratio
The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.
- Personalis, Inc. pe ratio for the quarter ending 2026-06-30 was -13.3, a change of -6.93 year-over-year.
- Personalis, Inc. pe ratio for the quarter ending 2026-03-31 was -6.97, a change of -3.29 year-over-year.
- Personalis, Inc. pe ratio for the quarter ending 2025-12-31 was -10.04, a change of -3.99 year-over-year.
- Personalis, Inc. pe ratio for the quarter ending 2025-09-30 was -7.84, a change of -3.69 year-over-year.
- Personalis, Inc. pe ratio for fiscal 2026 was -13.3.
- Personalis, Inc. pe ratio for fiscal 2025 was -10.04, a change of -3.99 from fiscal 2024.
- Personalis, Inc. pe ratio for fiscal 2024 was -6.06, a change of -5.08 from fiscal 2023.
- Personalis, Inc. pe ratio for fiscal 2023 was -0.98, a change of -0.16 from fiscal 2022.
- Available history
- 2019-06-30 to 2026-06-30
- Data captured
Historical PE Ratio
Annual PE Ratio
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |